Megan Rosengarten

Megan Rosengarten

Director/Board Member at NEURONETICS, INC.

Net worth: 408 836 $ as of 2024-03-30

47 year
Health Technology
Consumer Services
Technology Services

Profile

Megan Rosengarten is an Independent Director at Neuronetics, Inc. and a Director at Early Bird Medical, Inc. She previously worked as a Director at BioCT, Digital Surgery Ltd., and Medtronic, Inc., and as the VP-Breast & Skeletal Health Global Marketing at Hologic, Inc. Ms. Rosengarten received her undergraduate degree from Duke University and her MBA from Kenan-Flagler Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-31 85,890 ( 0.29% ) 408 836 $ 2024-03-30

Megan Rosengarten active positions

CompaniesPositionStart
NEURONETICS, INC. Director/Board Member 2021-08-01
Director/Board Member 2022-12-31
All active positions of Megan Rosengarten

Former positions of Megan Rosengarten

CompaniesPositionEnd
Director/Board Member 2022-05-31
Corporate Officer/Principal 2022-04-30
HOLOGIC, INC. Corporate Officer/Principal 2017-12-31
See the detail of Megan Rosengarten's experience

Training of Megan Rosengarten

Duke University Undergraduate Degree
Kenan-Flagler Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Megan Rosengarten's experience

Connections

63

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
HOLOGIC, INC.

Health Technology

NEURONETICS, INC.

Health Technology

Private companies3

Health Technology

Technology Services

Health Services

See company connections
  1. Stock Market
  2. Insiders
  3. Megan Rosengarten